Hence, in clinical diagnosis and treatment, serum marker tests for A2M, LBP, CTSG, CST3, and FABP1 should be prioritized in patients with a high suspicion of stroke for early detection and timely intervention. The gene discussed is FABP1; the disease is stroke disorder.